INNOVIVA, INC. Accounts Payable
INNOVIVA, INC. (INVA) had Accounts Payable of $4.02 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $4.02M.
- 2026-03-31: Accounts Payable, Current $6.52M.
- 2025-12-31: Accounts Payable, Current $4.97M.
- 2025-09-30: Accounts Payable, Current $6.24M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $4.02M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $6.52M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $4.97M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $6.24M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $5.38M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.70M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.13M 10-K · filed 2026-02-25 |
| 2024-09-30 | $4.17M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.04M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $890.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $6.72M 10-K · filed 2025-02-26 |
| 2023-09-30 | $3.78M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $4.59M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $5.93M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.94M 10-K/A · filed 2024-03-05 |
| 2022-09-30 | $3.81M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.32M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $1.81M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $27.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $89.00K 10-Q · filed 2021-10-27 |
| 2021-06-30 | $30.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $14.00K 10-Q · filed 2021-04-28 |
| 2020-12-31 | $66.00K 10-K/A · filed 2022-03-17 |
| 2020-09-30 | $623.00K 10-Q · filed 2020-10-28 |
| 2020-06-30 | $195.00K 10-Q · filed 2020-07-29 |
| 2020-03-31 | $122.00K 10-Q · filed 2020-04-29 |
| 2019-12-31 | $10.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $35.00K 10-Q · filed 2019-10-30 |
| 2019-06-30 | $1.14M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $144.00K 10-Q · filed 2019-05-01 |
| 2018-12-31 | $11.00K 10-K · filed 2020-02-19 |
| 2018-09-30 | $109.00K 10-Q · filed 2018-10-31 |
| 2018-06-30 | $58.00K 10-Q · filed 2018-07-26 |
| 2018-03-31 | $66.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $601.00K 10-K · filed 2019-02-19 |
| 2017-09-30 | $629.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $277.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.30M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $128.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | $528.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $137.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $576.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $818.00K 10-K · filed 2017-02-28 |
| 2015-09-30 | $154.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $462.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.02M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-24 |
| 2014-09-30 | $573.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $1.80M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $5.55M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $7.58M 10-K · filed 2015-02-27 |
| 2013-09-30 | $5.73M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $4.83M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $3.52M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $5.38M 10-K · filed 2014-03-03 |
| 2012-09-30 | $4.76M 10-Q · filed 2012-10-31 |
| 2012-06-30 | $4.99M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $5.31M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $5.81M 10-K · filed 2013-02-26 |
| 2011-09-30 | $3.70M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $2.17M 10-Q · filed 2011-08-03 |
| 2010-12-31 | $2.13M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |